Pathkey.AI Ltd (ASX:PKY)
Australia flag Australia · Delayed Price · Currency is AUD
0.0240
+0.0010 (4.35%)
At close: Oct 10, 2025

Pathkey.AI Company Description

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia.

The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs.

It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations.

The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025.

Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.

Pathkey.AI Ltd
CountryAustralia
Founded1994
IndustryMetal Mining
CEOSaurabh Jain

Contact Details

Address:
6 Middlemiss Street
Sydney, 2060
Australia
Phone61 3 9923 1222
Websitepathkey.ai

Stock Details

Ticker SymbolPKY
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000415291
SIC Code1000

Key Executives

NamePosition
Saurabh JainChief Executive Officer and Executive Chairman
Damon RasheedChief Technology Officer and Executive Director
Mark ZiirsenChief Financial Officer
Bernice AverionHead of Marketing and Communications
Shane LewisVice President of Sales and Partnerships
Matt HallamChief Revenue Officer
Jonathan Hart B.Com., L.L.B.Company Secretary